Patents Assigned to CERNER INNOVATION
  • Patent number: 11429885
    Abstract: Technologies are provided for identifying individuals having a risk of non-adherence to or from a prescribed treatment program; for predicting and the risk, which may be determined as a forecast over a future time span; and evaluating it to further determine or invoke specific actions to mitigate the risk or otherwise improve likelihood of compliance. A singular spectrum analysis (SSA) is utilized to analyze temporal properties of a time series determined from measured or observational data to determine an emergent pattern. Based on this pattern, a risk of non-adherence, including relapse or absconding, over a future time interval by the individual may be determined and utilized to implement an intervening action.
    Type: Grant
    Filed: December 21, 2017
    Date of Patent: August 30, 2022
    Assignee: CERNER INNOVATION
    Inventor: Douglas S. McNair